Jiangtong Peng

945 citations
23 papers · 761 indexed · h-index 15
Topics
interferon and immune responses (2 papers)Cardiovascular Disease and Adiposity (2 papers)MicroRNA in disease regulation (2 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Jiangtong Peng

23 papers receiving 754 citations

Peers

Jiangtong Peng
Comparison fields: 5 of 84
  • Molecular Biology 525
  • Cancer Research 257
  • Cardiology and Cardiovascular Medicine 146
  • Epidemiology 108
  • Immunology 87
Replace Shenglin Ge with:
Shenglin Ge China
Ke‐Qiong Deng China
Junsuk Ko United States
Daile Jia China
Vidar Beisvåg Norway
Baohua Yang China
Lian Xu China
Xuemei Yu China
Jumo Zhu China
Haoxiao Zheng China
Jiangtong Peng relative to Shenglin Ge China Shenglin Ge's profile →
Citations per field
00.5×1.5×2.3×
Shenglin Ge · 1×
Citations per year

Countries citing papers authored by Jiangtong Peng

Since Specialization
Citations

This map shows the geographic impact of Jiangtong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangtong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangtong Peng more than expected).

Fields of papers citing papers by Jiangtong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangtong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangtong Peng. The network helps show where Jiangtong Peng may publish in the future.

Co-authorship network of co-authors of Jiangtong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangtong Peng. A scholar is included among the top collaborators of Jiangtong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangtong Peng. Jiangtong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 11
4 20
5 13
6 7
7 29
8 43
9 24
10 16
11 28
12 47
13 12
14 22
15 33
16 7
17 27
18 22
19 117
20 40

About Jiangtong Peng

Jiangtong Peng is a scholar working on Cancer Research, Geriatrics and Gerontology and Hepatology, having authored 23 papers that have together received 761 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), Cardiovascular Disease and Adiposity (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (257 citations), Molecular Biology (525 citations) and Cardiology and Cardiovascular Medicine (146 citations). Jiangtong Peng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yutian Li, Tianqing Peng, Guo‐Chang Fan, Kobina Essandoh, Xiaohong Wang, Liwang Yang, Dongze Qin, Yigang Wang, Wei Huang and Xingjiang Mu. Their work appears in journals such as Journal of Biological Chemistry, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026